RxDoctor Payments DataLook up a doctor →

John Davis, MD

Otolaryngology · Hoover, ALNPI 1124113501

Payments from drug & device makers

$343,595in general payments, 2019–2025

Across 490 payments — averaging $701.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Aerin Medical Inc.$88K
  • Regeneron Healthcare Solutions, Inc.$66K
  • Sanofi$55K
  • GSK$47K
  • Regeneron$39K
  • Sanofi US Services Inc.$23K
  • plus $25K from 20 others
$46,902in research payments, 2019–2025

Across 27 payments — averaging $1737.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Neurent Medical Limited$46K
  • Sanofi US Services Inc.$958
  • Regeneron$313

What the payments were for

  • Consulting fees$63,99526%
  • Speaking & faculty fees$159,47364%
  • Travel & lodging$16,3827%
  • Food & beverage$10,8944%
  • Education$980%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$343,595 in reported general payments places this provider in the 95th percentile of 155 otolaryngology providers in Alabama.

See all otolaryngology providers in Alabama

Medicare billing

Part B allowed, 2024
$183,086
Medicare patients
275
Services billed
1,390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab12$44,296
Dexlansoprazole DrDexlansoprazole35$9,779
Omeprazole136$1,878
Ipratropium Bromide60$1,745
Azelastine Hcl43$1,061
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav72$785
Esomeprazole Magnesium12$782
Pantoprazole Sodium47$733
Cefdinir29$683
Montelukast Sodium58$580
Ondansetron OdtOndansetron38$446
Ofloxacin11$444
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen30$391
Famotidine24$306
Prednisone76$269

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Hoover

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →